CompanyDrug

HuidaGene Receives FDA IND Approval for Ophthalmology Gene Therapy HG004

CompanyDeals

Yinghe Brain Science Raises RMB 100 Million in Angel Financing Round

CompanyDeals

HutchMed Signs Licensing Deal with Takeda for Global Fruquintinib Development

CompanyDeals

Tianjin-Based Protein T Raises RMB 100 Million in Series A Financing

CompanyDrug

Ascletis Receives IND Approval for ASC10 in Monkeypox Treatment

CompanyDrug

Legend Biotech’s Carvykti Meets Primary Endpoint in CARTITUDE-4 Phase III Study

CompanyDrug

CSPC’s Octreotide Long-Acting Injection Approved for Acromegaly Clinical Study

CompanyDrug

BeiGene’s Brukinsa Approved by FDA for Chronic Lymphocytic Leukemia

CompanyDeals

Dartsbio Pharmaceuticals Secures RMB 100 Million in Series B Financing

CompanyDrug

CNBG-Virogin’s Omicron-Targeted mRNA Vaccine Approved for Clinical Trials

CompanyDrug

Hepagene’s FXR Agonist HPG1860 Shows Positive Phase IIa Data in NASH Study

CompanyDeals

Ascentage Pharma Raises HKD 550 Million in Secondary Offering for Pipeline Expansion